Business

Christina Lake Cannabis Agrees to $15M Buyout Talks With Alberta Purchaser

mm
Add MyCannabis.com to your preferred sources on Google

Christina Lake Cannabis Corp. has signed a non-binding letter of intent with an unnamed private Alberta corporation that would see the buyer acquire all of the British Columbia outdoor grower’s outstanding shares in a transaction valuing its equity at $15 million, the company announced on August 21, 2026.

The letter, dated August 20, 2026, commits the two sides to good-faith due diligence and negotiation of a definitive agreement. Christina Lake’s board approved entering the letter after what the release describes as an extensive period of negotiation and consideration of alternatives, and a special committee of the board has been formed to steer the process and make a recommendation before any definitive agreement is signed or put to shareholders.

The $15 million figure is a fully-diluted, cash-free, debt-free equity value, and the company was explicit that it is not a per-share price. What shareholders would actually receive in cash is the amount left over once all outstanding debt, including convertible debentures, and transaction expenses are paid out of that figure, distributed pro rata. The per-share consideration cannot be calculated yet and is to be disclosed in a management information circular ahead of a special shareholder meeting.

How the Proposed Transaction Would Be Structured

No final structure has been chosen. The company currently expects a court-approved plan of arrangement, but the letter leaves the buyer free, acting reasonably after due diligence, to opt instead for a statutory amalgamation or a formal take-over bid, in each case built to satisfy corporate, securities, tax and stock exchange requirements, including minority protections.

The letter carries a 120-day exclusivity period from its August 20, 2026 date, during which Christina Lake will deal exclusively with the purchaser on diligence and definitive terms. The exclusivity has customary carve-outs: the board kept the right to engage with unsolicited bona fide offers it determines would produce a more favourable transaction for shareholders, on the basis that refusing such discussions would be inconsistent with its fiduciary duties.

Deal protection terms would only bite if a definitive agreement is signed. Those contemplated include non-solicitation covenants, a fiduciary out, matching rights for the purchaser, a $450,000 termination fee payable by the company in certain circumstances including acceptance of a superior proposal, and reimbursement of the purchaser’s documented out-of-pocket expenses up to $450,000 in the event of a wilful breach. No termination fee or expense reimbursement is payable under the letter itself.

Debt Retirement and Cancellation of Equity Rights

The proposed transaction is designed to close on a cash-free, debt-free basis with economic effect as of October 30, 2026. At or before closing, every form of company indebtedness would be repaid or discharged in full: its operating or revolving line of credit, bank debt, shareholder loans, equipment financing, and convertible debentures, together with accrued interest and any prepayment penalties or make-whole amounts.

All outstanding options, warrants, restricted share units, deferred share units, performance share units and similar rights would be terminated for no consideration, whether vested, exercisable or in-the-money. The convertible debentures, which the company expects to be out-of-the-money at the $15 million equity value, would be treated as debt and repaid or redeemed in full, with all conversion and equity participation rights cancelled. Surplus cash on hand at the effective date may be distributed to shareholders at or before closing, subject to the letter’s terms.

What Happens Next for Christina Lake Cannabis Shareholders

The letter terminates on the earliest of several triggers: execution of a definitive agreement, expiry of the exclusivity period, mutual written termination, or January 30, 2027. If a definitive agreement is executed, the company expects to hold a special shareholder meeting to approve the transaction, with full terms set out in a circular mailed to shareholders and filed, along with the agreement itself, on the company’s SEDAR+ profile. Depending on the final structure, approvals may also be required from the applicable court and the Canadian Securities Exchange. The company says no action is required of shareholders at this stage, and no finder’s fees are payable in connection with the proposed transaction.

The release stresses that the letter is non-binding and that completion depends on the purchaser’s due diligence, definitive terms, a special committee recommendation and board approval, with no assurance any transaction results.

The Outdoor Grower Behind the Deal

Christina Lake Cannabis is a licensed producer under the federal Cannabis Act, holding a standard cultivation licence with a processing amendment from Health Canada plus a research and development licence. Its operations sit in lower interior British Columbia near the U.S. border: a 32-acre property with over 950,000 square feet of outdoor grow space, propagation and drying rooms, research facilities and a dedicated processing and extraction building, plus a 342-acre property with roughly 100 acres of licensed outdoor grow space, greenhouses and a dry room. The company sells outdoor flower, extracts and distillate to business-to-business customers.

The company secured its cultivation licence in March 2020, added the processing amendment that August, and in 2024 raised money through secured convertible promissory notes, an initial $1,925,000 tranche bearing 10 to 20 percent annual interest and convertible at $0.05 per share, to upgrade newly acquired equipment and facilities. In July 2025 the company filed its audited financial statements for the year ended February 28, 2025, a filing expected to trigger revocation of a management cease trade order that had barred directors and officers from trading its securities. Prelia Canada LLP is acting as the company’s legal advisor on the proposed transaction.

Daniel Price is an AI-generated analyst at MyCannabis.com, covering Canada’s regulated cannabis market with a focus on policy outcomes, market structure, and industry performance following legalization. His work examines how regulatory decisions translate into real-world effects for consumers, licensed producers, retailers, and public markets.

With a and institutional perspective, Daniel analyzes licensing frameworks, retail expansion, pricing dynamics, and post-legalization reforms across Canada’s cannabis ecosystem. He pays particular attention to how regulation shapes competition, consumer access, and long-term market sustainability.

Articles authored by Daniel Price are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, context, and responsible coverage of cannabis markets in fully legalized jurisdictions.